The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2025
Filed:
Aug. 19, 2021
Applicant:
Jacobio Pharmaceuticals Co., Ltd., Beijing, CN;
Inventors:
Qinghao Liu, Beijing, CN;
Jun Tao, Beijing, CN;
Wenlai Zhou, Beijing, CN;
Shanshan He, Beijing, CN;
Haiyan Yang, Beijing, CN;
Hongling Wang, Beijing, CN;
Guiqun Yang, Beijing, CN;
Assignee:
JACOBIO PHARMACEUTICALS CO., LTD., Beijing, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2005.12); A61P 35/00 (2005.12); C07K 16/28 (2005.12); C07K 16/46 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2866 (2012.12); A61P 35/00 (2017.12); A61K 2039/505 (2012.12); C07K 2317/24 (2012.12); C07K 2317/31 (2012.12); C07K 2317/55 (2012.12); C07K 2317/565 (2012.12); C07K 2317/569 (2012.12); C07K 2317/622 (2012.12); C07K 2317/732 (2012.12); C07K 2317/94 (2012.12);
Abstract
Provided is a binding molecule specific for LIF and use thereof. Specifically, provided is an isolated antibody or an antigen-binding fragment thereof that binds to LIF and inhibits the activity of LIF. Also provided are uses of the isolated antibody or the antigen-binding fragment thereof in treatment of diseases.